Biotec Pharmacon Asa

Rolf Seljelid

Rolf Einar Engstad

The invention relates to a glucan having a beta-(1,3)-backbone with one or more beta-(1,3)-side chains linked thereto for use in the treatment of asthma and related diseases of abnormal pulmonary function in an animal. Also described is a method of treating asthma and related diseases of abnormal pulmonary function in an animal comprising administering to said animal an effective amount of a glucan having a beta-(1,3)-backbone with one or more beta-(1,3)-side chains linked thereto.

Medical uses of glucans

A method of treating an ulcer comprising applying to the ulcer a preparation comprising a water-soluble &#x3b2;-(1,3) glucan with &#x3b2;-(1,6) linked side-chains, where the side-chains comprise &#x3b2;-(1,3) linkages or up to four consecutive &#x3b2;-(1,6) linkages a active ingredients.

Methods of skin treatment and use of water-soluble &#x3b2;-(1,3) glucans as active agents for producing therapeutic skin treatment agents

A method of treating an ulcer comprising applying to the ulcer a preparation comprising a water-soluble &#x3b2;-(1,3) glucan with &#x3b2;-(1,6) linked side-chains, where the side-chains comprise &#x3b2;-(1,3) linkages or up to four consecutive &#x3b2;-(1,6) linkages as active ingredients.

The invention relates to new etherified carbohydrate derivatives, a method for production thereof, pharmaceutical compositions containing the same and use for the production of a pharmaceutical preparation for treatment of conditions in which macrophages are stimulated or down-regulated. In an embodiment of the present invention, said carbohydrate derivatives comprise general formula (I) wherein n is an integer in the range from 3 to 98, and each group R independently represents a hydrogen atom or an aliphatic, saturated or unsaturated hydrocarbon chain having from 7 to 30 carbon atoms.

Growing community of inventors

Tromsø, Norway

Rolf Seljelid